Last reviewed · How we verify
NCT07023887: EXERT-BCHC
Prospective Study of EXErcise Regimens After Treatment for Breast Cancer for Hypertrophy and Conditioning
trial testing 6-12-25 Training Regimen in Cancer in 15 participants. Currently enrolling.
15 July 2026
Quick facts
| Lead sponsor | Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute) |
|---|---|
| Status | Recruiting now |
| Study type | OBSERVATIONAL |
| Enrollment | 15 |
| Start date | 21 May 2025 |
| Primary completion | 15 July 2026 |
| Estimated completion | 15 October 2026 |
| Sites | 1 location across United States |
Drugs / interventions tested
- 6-12-25 Training Regimen
- 8x8 Training Regimen
- 5/5/5 Cluster Set Training Regimen
- Double Training Regimen
Conditions studied
- Cancer — all drugs for Cancer →
- Breast Cancer — all drugs for Breast Cancer →
Sponsor
Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)
Who can join
Adults 20 to 89, female only, with Cancer or Breast Cancer. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study investigates the impact of four standard of care, monitored group exercise regimens (resistance training) on conditioning and hypertrophy in women previously treated for breast cancer. The study will compare two conditioning regimens (6-12-25 and 8x8) and two hypertrophy regimens (5/5/5 cluster sets and double training) to assess changes in VO2 max, muscle mass, and fat mass.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07023887
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Cancer
Currently open trials in the same condition.
- NCT07390045 — Exercise and Cognitive Rehabilitation Interventions for Older Cancer Survivors · NA · recruiting
- NCT07528547 — Hypersight and Ethos In Pediatric Radiotherapy · NA · recruiting
- NCT07481890 — Feasibility and Efficacy of the EMDR Toolbox Method in Cancer Patients. · NA · recruiting
- NCT07402057 — Implementation and Evaluation of a Program Aimed at Facilitating Palliative Care Conversations · NA · recruiting
- NCT07305740 — On-Trac: An Online Intervention for Cancer Survivors Managing Anxiety · NA · recruiting
Other Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute) trials
Trials by the same sponsor.
- NCT07430085 — Post-Operative Pain Relief: Zynrelef or Periarticular Injections in RATKA · Phase 4 · not yet recruiting
- NCT06712290 — Connective Tissue Matrix Compared to Steroid Injections for Rotator Cuff Tendinopathy · NA · withdrawn
- NCT06610396 — Ex Onc SLED: a Study Utilizing a Weighted Sled for Horizontal Resistance Training · recruiting
- NCT05194462 — Home Biofeedback or Pelvic Floor Physical Therapy for Postpartum Urinary Incontinence. · NA · terminated
- NCT06160427 — Connective Tissue Matrix for Rotator Cuff Tendinopathy · Phase 4 · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07023887 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)
- Last refreshed: 4 February 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07023887.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing